Over 20 years of radioimmunoassays for diabetes diagnostics!
20 years of radioimmunoassays
(firmenpresse) - 20 years of radioimmunoassays for diabetes diagnostics - Why should radioactive test reagents still be used in diagnostics, as nowadays more and more people disapprove radioactive technology? To put it simple: many areas of modern medicine would not be possible without the use of radioactive treatments, and in the field of diagnostics there are many radioactive test reagents that are still recognized as gold standard methods.
Today the number of companies still offering radioimmunoassay (RIA) reagents is becoming smaller and smaller. We at MEDIPAN are proud to announce that we continue to manufacture RIAs for diabetes diagnostics (with parameters such as anti-GAD, anti-IA2 and insulin for type 1 diabetes) and to continue providing these to diagnostic laboratories, allowing to keep up the gold standard method for the sensitive and efficient detection of type 1 diabetes.
Themen in dieser Pressemitteilung:
radioimmunoassays
radioimmunoassay
ria
elisa
medicine
healthcare
diagnostic
diagnostics
diabetes
autoimmun-disease
autoimmunity
laboratory
press
medizintechnik
diagnostik
medizinische-diagnostika
diabetes-type-1
Unternehmensinformation / Kurzprofil:
Medipan GmbH, located at the borders of Berlin, develops, manufactures and markets tests for the diagnosis of autoimmune diseases since 1992.
Medipan GmbH
Ludwig-Erhard-Ring 3
15827 Dahlewitz
Germany
Phone: 0049-33708-44170
Mail: a.hartwig(at)medipan.de
Press Contact:
Mrs Angela Hartwig
Medipan GmbH
Ludwig-Erhard-Ring 3
15827 Dahlewitz
Germany
Phone: 0049-33708-44170
Mail: a.hartwig(at)medipan.de
Datum: 19.01.2018 - 16:20 Uhr
Sprache: Deutsch
News-ID 571158
Anzahl Zeichen: 936
contact information:
Contact person: Angela Hartwig
Town:
Dahlewitz
Phone: 00493370844170
Kategorie:
Healthcare & Medical
Typ of Press Release: Produktinformation
type of sending: Veröffentlichung
Date of sending: 19.01.2018
Diese Pressemitteilung wurde bisher 290 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Over 20 years of radioimmunoassays for diabetes diagnostics!"
steht unter der journalistisch-redaktionellen Verantwortung von
Medipan GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
